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Abstract Objective Themoment of admission for delivery may be inappropriate for offering an
intrauterine device (IUD) to women without prenatal contraception counseling.
However, in countries with high cesarean rates and deficient prenatal contraception
counseling, this strategy may reduce unexpected pregnancies and repeated cesarean
sections.
Methods This was a prospective cohort study involving 100 women without prenatal
contraception counseling. Postplacental IUD was offered after admission for delivery
and placed during cesarean. The rates of IUD continuation, uterine perforation, and
endometritis were assessed at 6 weeks and 6 months, and the proportion of women
continuing with IUD at 6 months was assessed with respect to the number of previous
cesareans.
Results Ninety-seven women completed the follow-up. The rate of IUD continuation
was 91% at 6 weeks and 83.5% at 6 months. The expulsion/removal rate in the first
6 weeks was not different from that between 6 weeks and 6 months (9 vs 9.1%,
respectively). There were 2 cases of endometritis (2.1%), and no case of uterine
perforation. Among 81 women continuing with intrauterine device after 6-months,
31% had undergone only the cesarean section in which the IUD was inserted, 44% had
undergone 2 and 25% had undergone 3 or more cesarean sections.
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Intrauterine device (IUD) is an effective contraceptive method
for postpartum period, with the advantages over hormonal
methodsofbeing independentofwomen’s complianceandnot
affecting the coagulation system or lactation.1
Intrauterine device placement is usually performed
6 weeks following delivery (interval insertion), due to
evidence indicating a lower expulsion rate when compared
with immediate postplacental insertion.2 However, in real
life setting, women experience difficulties to return for a
postpartum visit, and it was reported that almost half of
the women who had the intention of using IUD for post-
partum contraception turned out not to have an IUD
inserted.3 In face of these limitations of interval IUD
placement, there has been growing interest on immediate
insertion. Immediate insertion is associated with an overall
low expulsion rate, of around 10%,4 which is significantly
lower when following cesarean when compared with vagi-
nal delivery.4–6
Brazil has an estimated population of over 200 million
inhabitants and is among the countries with the highest
cesarean delivery rate.7 Despite most women having access
to prenatal care in Brazil,8 postpartum contraception is not
discussed frequently,9 and health care providers view the
moment of delivery as an inadequate setting to provide
information about IUD and for women to decide whether
they want it to be inserted or not.
In Brazil, almost two thirds of the women admitted to
delivery are aged under 29 years old.10 Moreover, cesarean
delivery rates are around 56%, and there is an established
practice of avoiding vaginal delivery in women with 2 or
more previous cesarean sections. It is, therefore, possible
that offering postplacental IUD insertion to women who are
going to have a cesarean delivery, regardless of whether or
not they received prenatal contraception counseling, would
be an effective strategy to avoid repeated cesarean sections
in young women.
The primary objective of this study was to determine the
rates of IUDcontinuation,uterineperforationandendometritis
after 6 weeks and 6 months in women for whom IUD contra-
ception was offered at admission for delivery, immediately
after the indication of a cesarean section, and inserted after
placental delivery. The secondary objectivewas to estimate the
proportion of women for whom the abovementioned strategy
of immediate IUDinsertionpotentiallyavoidedathirdor fourth
cesarean section.
Conclusion Two thirds of the women who continued with IUD at 6 months had
undergone 2 or more cesarean sections. Since offering trial of labor is unusual after 2 or
more previous cesareans, we believe that offering IUD after admission for delivery may
reduce the risk of repeated cesarean sections and its inherent risks.
Resumo Objetivo O momento da admissão para o parto pode ser considerado inapropriado
para oferecer o dispositivo intrauterino (DIU) para mulheres sem aconselhamento
contraceptivo pré-natal. Entretanto, em países com elevadas taxas de cesáreas e
aconselhamento contraceptivo deficiente, essa estratégia pode reduzir o risco de
gestações não programadas e cesáreas repetidas.
Métodos Estudo de coorte envolvendo 100 mulheres sem aconselhamento contra-
ceptivo pré-natal. A inserção de DIU pós-dequitação foi oferecida após a admissão para
o parto e indicação de cesárea. As taxas de continuidade com o DIU, perfuração uterina
e endometrite foram avaliadas após 6 semanas e 6 meses, e a proporção de mulheres
que continuaram com o DIU após 6 meses foi analisada em relação ao número de
cesáreas prévias.
Resultados Noventa e sete mulheres completaram o seguimento. A taxa de perma-
nência do DIU foi de 91% em 6 semanas e 83,5% em 6 meses. A taxa de expulsão/
remoção nas primeiras 6 semanas foi não foi diferente daquela observada entre 6
emanas e 6 meses (9 vs 9,1%, respectivamente). Houve dois casos de endometrite
(2,1%), e nenhum caso de perfuração uterina. Entre as 81mulheres que permaneceram
com o DIU após 6meses, 31% haviam sido submetidas a apenas uma cesárea, em que o
DIU foi inserido, 44% a 2, e 25% a 3 ou mais cesáreas.
Conclusão Dois terços das mulheres que continuaram com o DIU após 6 meses
haviam sido submetidas a 2 oumais cesáreas. Considerando que oferecer a tentativa de
parto vaginal após duas ou mais cesáreas prévias é incomum, é possível que a oferta do
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Methods
This was a prospective cohort study conducted between
February 2012 and June 2013, at the Hospital Universitário
de Brasília, DF, Brazil. It was approved by the Ethics Committee
(register number 183/11) of the institution and conducted
according to the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) guidelines for cohort stud-
ies. Pregnant women aged 18 years or over for whom cesarean
delivery was indicated after admission were included when
both the woman and the medical staff on duty agreed to
participate. The exclusion criteria were as follows: women
with a personal history of dysmenorrhea or menorrhagia,
with a high risk of sexually transmitted disease (arbitrarily
defined asmore than one sex partner over the last 6months or
over the period of 6months preceding pregnancy, or a positive
human immunodeficiency virus, venereal disease research
laboratory or hepatitis B virus antigen test during pregnancy),
gestational age of less than 32 weeks at the time of delivery,
fever over the last 48 hours, membrane rupture for over
12 hours before delivery and signs of vaginitis or cervicitis
on gynecological examination.
Immediately after indication of cesarean section, thewom-
enwere offered the possibility of IUD insertion during surgery,
and all their doubts about this contraception method were
clarified. Those who agreed with insertion signed a written
informed consent. Following placental delivery, the IUD (mod-
el TCu380A, Injeflex, São Paulo, SP, Brazil)was insertedusing a
standard technique: while one of the surgeon’s hand held the
outer face of the fundus of the uterus, the other hand, with the
IUD between the second and third fingers, inserted the device
in the fundus through the hysterotomy incision and, after this,
directed the strings to the cervix, without cutting them. The
IUD was inserted by the medical residents or staff on duty,
who had received a brief training provided by the researchers.
All participants received one to two grams of cefazolin pro-
phylaxis before cesarean section.
To avoid follow-up losses, all participants received a phone
number tocontact theresearchersover thefollowing6months,
if necessary. The women returned for postpartum visits with
the researchers after 6 weeks and 6 months and underwent
gynecological examinationand transvaginal sonographyat the
Hospital Universitário de Brasília. For women who had not
undergone oncologic colpocytology assessment during preg-
nancy, thiswas done in the 6-week visit.When the participant
missed one of the postpartum visits and phone contact was
unsuccessful, the researchers visited the women in her resi-
dency to make the visit to the hospital feasible.
The IUD was considered adequately positioned at the 6-
week and 6-month visits if it was inside the uterine cavity,
above the internal cervical os. Expulsion was defined as total
exteriorization of the IUD or when transvaginal sonography
showed the device was inside the cervical canal. In the latter
situation, the IUD was immediately extracted. Intrauterine
device removal was defined by removal of the device, due to
any reason, when it was situated above the internal cervical
orifice. Statistical analysis was conducted using Graphpad
Prism software, version 7.0 (GraphPad Software Inc., La Jolla,
CA, USA). The Chi-squared and Fisher exact testswere used to
compare proportions, and one-way analysis of variance
(ANOVA) was used to comparemeans. Statistical significance
was considered when the p-value was lower than 0.05.
Results
One hundred women were included in the study, and their
characteristics are presented in table 1. The mean age of the
participants was 27.7 (5.6) years (95% confidence interval
26.6–28.7 years). Two thirds of the participants had at least a
previous cesarean section, and one in every five participants
had two or more previous cesarean sections (►Table 1).
Among the 100 participants, 99 returned for the 6-week
visit (►Fig. 1). Five of them (5.1%) presented IUD expulsion,
and one underwent IUD removal due to endometritis. Two
women requested IUD removal at this visit due to excessive
bleeding, and one requested removal after being informed
that the device was rotated to the transversal position (i.e.
the main axis of the IUD was perpendicular to the main
uterine axis), despite being asymptomatic. Therefore, 90
(90.9%) women remained with the IUD after 6 weeks of
insertion during cesarean delivery (►Fig. 1).
A total of 88 women returned for the 6-month visit, and 3
(3.4%) of them had IUD expulsion. One woman presented
endometritis between the 6-week and 6-month visits and
was treatedwith antibiotics without IUD removal, with good
response. Two women requested IUD removal at this visit
because of excessive bleeding, and two requested removal
after being informed that the device was rotated to the
transversal position, despite being asymptomatic. Therefore,
81 (83.5%) of the participants remained with the IUD after
6 months (►Fig. 1). Among these women, the strings were
visible during gynecological assessment in 31 (38.3%).




< 25 33 (33)
25-34 52 (52)
 35 15 (15)
Previous deliveries
None 21 (21)




2 or more 22 (22)
Gestational age at delivery (weeks)
< 37 5 (5)
37-40 þ 6 77 (77)
41 or more 18 (18)
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The expulsion/removal rate during the first 6 weeks after
insertion (9.1%) was similar to that observed between
6 weeks and 6 months of insertion (9%, p > 0.05). When
only women presenting expulsion were considered, there
was also no difference between both time points (5.1% at the
6-week visit vs. 3.4% at the 6-month visit, p > 0.05). Among
the 97 women who completed follow-up, 81 (83.5%)
remained with the IUD 6 months after cesarean delivery, 8
(8.2%) presented expulsion, and 8 (8.2%) requested its
removal. There were no cases of uterine perforation. There
was no difference between women who remained with the
IUD at 6 months and women with IUD expulsion/removal
with respect to age, parity, the number of previous cesarean
deliveries or gestational age at delivery (►Table 2).
Among the 81 women who remained with the IUD
6 months following the delivery, 25 (30.8%) had undergone
only the cesarean section in which the device was inserted,
36 (44.4%) had undergone 2 cesarean sections, 18 (22.2%)
had undergone 3 cesarean sections, and 2 (2.5%) had
undergone 4 cesarean sections. Therefore, taking into
account that offering vaginal delivery for women who
have undergone 2 or more previous cesarean sections is
exceptional in Brazil, IUD insertion hypothetically pre-
vented the 3rd, 4th and 5th cesarean sections in 36, 18 and
2 of the participants, respectively. There was no statistically
significant difference among women who had undergone
one, two, three or more cesarean sections with respect to
age (►Fig. 2).
Fig. 1 Six-month follow-up of 100 participants for whom IUD insertion was offered immediately after the indication of a cesarean section and
inserted after placental delivery.
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Discussion
In the present study, we found that offering IUD contraception
immediately before cesarean delivery, followed by device
insertion during surgery, was an effective strategy, since after
6 weeks the rate of IUD permanence was 90%. This strategy is
also possibly more convenient, because women who wish to
use IUD contraception do not need to return early in the
postpartum, aperiodwithwell-knowndifficulties.3Moreover,
the fact that there was no difference in the expulsion rate
during thefirst 6weeksand in theperiodbetween6weeksand
6 months reinforces the convenience of IUD insertion during
surgery, when the uterus is literally “in the hand and open”,
and the procedure can be carried out without any additional
expense.
Three previous studies, 2 conducted in Brazil and the other
in North America, reported a 100% rate of IUD continuation
6 months after insertion during cesarean section.6,11,12 How-
ever, 2 studies assessed a limited number of women (19 and
25),6,11 and in the other one, 52% of the 90 women included
were lost to follow-up.12 Since the rate of IUD expulsion is
overall low, it is expected that small samples comprise more
frequentlywomen inwhom the IUD remained in theuterus. In
addition, large losses to follow-up may impair data interpre-
tation, because it is not possible to conclude that the women
who did not return for follow-up were those more often
presenting IUD expulsion. These aspects may explain the
differences between the findings from previous studies6,11,12
and our data. We assessed 100 women and had a low rate of
loss to follow-up (3%). Intrauterine device permanence rates
after 6 weeks (90%) and 6 months (81%) were similar to those
reported by Çelen et al (93% and 82%, respectively), who
assessed 245 women and had no losses to follow-up.13
Levi et al14 recently reported an 83% IUD continuation rate
after 6 months among women randomly assigned for IUD
insertion during cesarean section. Despite the similarity with
our finding, the studies have methodological differences. In
particular, Levi et al14 inserted another IUD in the 3 partic-
ipants presenting expulsion and in the participant fromwhom
the initial devicewasremovedduetoendometritis, and these4
women were considered as cases of IUD permanence at
6 months. In the current study, we reported the continuation
rate of IUD exclusively inserted during the cesarean section,
and it could be expected that if the expulsed or removed IUDs
had been replaced the rate at 6 months would have been
higher. It is important to point that from a public health
perspective, immediate IUD replacement after expulsion or
removal could be an interesting strategy for increasing the
continuation rate in womenwho had the IUD inserted during
cesarean delivery.
Another approach to increase the continuation rate would
be to avoid unnecessary removal of IUDs inserted during
cesarean sections. Two participants (2.1%) included in our
study presented endometritis, one of them underwent IUD
removal, and the other one maintained the IUD and showed a
good response to antibiotic treatment. There are currently no
data to provide definitive recommendations for or against IUD
maintenance inwomenwith endometritis, and, therefore, the
Table 2 Comparision between the women who remained with









29.1  6.3 27.5  5.5 p ¼ 0.322a
Age (years)
< 25 27 (32.9%) 5 (33.3%) p ¼ 0.3187b
25–34 43 (52.4%) 7 (46.7%)
 35 12 (14.6%) 3 (20.0%)
Previous
deliveries
None 16 (19.5%) 5 (33.3%) p ¼ 0.3046c




None 25 (30.5%) 7 (46.7%) p ¼ 0.2193b
1 36 (43.9%) 7 (46.7%)




< 37 4 (4.9%) 1 (6.7%) p ¼ 0.8723b
37–40 þ 6 63 (76.8%) 12 (80%)
41 or more 15 (18.3%) 2 (13.4%)
Abbreviations: IUD, intrauterine device, SD, standard deviation.
aStudent t-test; bChi-square test; cFisher exact test.
Fig. 2 Age distribution of women with one, two, or three or more
cesarean sections. The mean  SD was 25.4 (5.6), 28.2 (5.5) and
28.9 (4.7) years, respectively (p > 0.05 by one-way analysis of
variance).
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best approach for treating these women is based on clinical
judgement. The Center for Diseases Control and Prevention
from North America recommends that women outside the
puerperium with inflammatory pelvic disease receiving IUD
contraception should be treated with antibiotics, and the
device should be removed only if there is no satisfactory
response to therapy after 48to 72h.15 We believe that this
recommendation could be extended towomenwith endome-
tritis following cesarean delivery, since this approach would
enable the assistant physician to determine, on an individual
basis, those women for whom antibiotic therapy should be
best accompanied by IUD removal.
An unexpected finding in our study was that eight women
exhibited IUD rotation to a transversal situation inside the
endometrial cavity in sonographic assessment. According to
criteria established in the study design, theywere considered to
bewellpositioned,but,onthebasisofradiologiccriteria, rotated
devices are considered malpositioned due to displacement.16
This finding was informed to all eight participants, and three of
them decided to remove the IUD despite being asymptomatic.
To our knowledge, this situation was not reported in previous
studies.Outside thepuerperium, IUDrotation isassociatedwith
pain and bleeding,16 and, in the current study, two participants
exhibiting IUD rotation requested its removal due to bleeding.
We, therefore, suggest that women showing IUD rotation and
presenting bleeding or feeling unsafe should undergo prompt
IUD replacement.
We did not observe any case of uterine perforation, a
complication that was also not reported in a study involving
over 17,000 women undergoing IUD insertion during cesar-
ean section in 6 different countries.5
Six months after insertion, IUD strings were visible in 38%
of the participants with well-positioned device. In this same
time period and using the same IUD model, data from other
studies indicated visible strings in between 4014 and 78% of
the participants.17 Both women and health care providers
should acknowledge that the strings may not be visible in
appropriately positioned IUDs that were inserted during
cesarean delivery.
By offering IUD insertion to women who had received no
prenatal contraception counseling, we challenged a common
dogma in Brazil: that the time point immediately before
cesarean delivery is an inadequate moment for the women to
receive counseling and freely decide about IUD insertion. Data
fromBrazilian studies indicate thatmostwomendonot receive
prenatal contraception counseling.9Among thosewhodo, after
delivery, only one third has access to the contraceptivemethod
thatwaschosen,withcontraceptive injectionbeing themethod
showing higher concordance between the women’s previous
choice and the method used in the puerperium, and IUD
showing the lowest concordance in this respect.18 Although
we believe that contraception counseling should be routinely
provided in prenatal care because this is the most effective
postpartum contraception strategy,5,19 we acknowledge that
not offering IUD insertion at the moment of delivery only
because the method was not discussed during the pregnancy
represents, indeed, a “second failure” in providing appropriate
contraception counseling.
The current study sought solutions for a common problem
in public Brazilian maternities. Since Brazil is the second
country with the higher cesarean section rate worldwide,7
with a population of young parturients, and a law system
Fig. 3 Suggested approach for offering postpartum contraception. IUD: Intrauterine device.
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that restricts surgical sterilization during cesarean delivery, it
is common that pregnant women younger than 30 years old
have a previous history of one or more cesarean deliveries.
Additionally, because vaginal delivery is exceptionally offered
for women who have undergone two or more cesarean
sections, thousands of young women are annually exposed
to the risks of repeated cesarean sections. In the current study,
we strongly believe that the cases inwhich the IUDs remained
in the endometrial cavity after 6 months of insertion poten-
tially prevented an additional cesarean section in two thirds or
the participants, since68%ofwomenwereundergoing the2nd,
3rd or even 4th cesarean delivery at the moment of IUD
insertion.
Women undergoing repeated cesarean sections are at
increased risk of bowel and urinary tract injury, but the
most feared complication is placenta accreta,20 which is
associated with high morbidity and mortality. Due to the
dramatic increase in the frequency of placenta accreta in the
United States over the last twodecades, the implementationof
centers of excellence formanaging this conditionwas recently
proposed.21 Despite the reduction in morbidity and mortality
when women with established placental accretism are man-
aged in these high complexity centers (tertiary prevention),
providing effective contraception would be an effective mean
to promote primary prevention of this condition.
It is important to point that, in the present study, there
was a great effort to avoid losses to follow-up, particularly at
the 6-week visit. This is a time period when women face
difficulties in returning to the health service. Assessment at
this time may, therefore, not reflect the real-life setting, and
therefore reinforces the importance of assuring that the
contraceptive method desired by the woman is provided at
discharge.
Our findings are limited by the fact that the participants
were recruited from only one center. However, the high rates
of cesarean deliveries are evenly distributed in the country,
and one may, therefore, speculate that the results of offering
IUD insertion at the moment of the indication of cesarean
sectionwould be similar among Brazilian public maternities.
In light of our findings, we strongly believe that health
care providers should not view the lack of antenatal contra-
ception counseling as a barrier to offering IUD insertion at
the time point of cesarean section indication. This approach
not only enables women to enjoy their sexual and reproduc-
tive rights but potentially discontinues a myriad of health
injuries. We hence propose a strategy to optimize contra-
ception in the postpartum period in ►Figure 3.
Conclusion
Our findings indicate a high rate of IUD continuation and low
rates of complications after postplacental insertion for wom-
en undergoing cesarean sections in a setting of high cesarean
delivery rates and deficient prenatal contraception counsel-
ing. Since offering trial of labor is unusual after two or more
previous cesareans, it is possible that offering IUD after
admission for delivery may reduce the risk of repeated
cesarean sections and its inherent risks.
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